PEB Share Price

Open 0.55 Change Price %
High 0.55 1 Day -0.01 -1.79
Low 0.54 1 Week -0.04 -6.78
Close 0.55 1 Month -0.04 -6.78
Volume 133412 1 Year 0.11 25.00
52 Week High 0.67
52 Week Low 0.38
PEB Important Levels
Resistance 2 0.56
Resistance 1 0.56
Pivot 0.55
Support 1 0.54
Support 2 0.54
NZE NewZealand Most Active Stocks
NPX 5.45 0.55%
NPX 5.45 0.55%
NPX 5.45 0.55%
TEL 2.87 0.00%
TEL 2.87 0.00%
TEL 2.87 0.00%
TEL 2.87 0.00%
DIL 7.03 0.00%
DIL 7.03 0.00%
CEN 4.94 0.41%
More..
NZE NewZealand Top Gainers Stocks
NWF 0.09 12.50%
NWF 0.09 12.50%
WDT 0.18 5.88%
XRO 18.75 2.35%
VCT 3.23 1.89%
VCT 3.23 1.89%
VCT 3.23 1.89%
NZO 0.65 1.56%
NZO 0.65 1.56%
DNZ 2.01 1.52%
More..
NZE NewZealand Top Losers Stocks
AIR 2.18 -2.68%
AIR 2.18 -2.68%
AIR 2.18 -2.68%
AIR 2.18 -2.68%
TPW 4.70 -2.08%
PEB 0.55 -1.79%
PEB 0.55 -1.79%
PEB 0.55 -1.79%
CAV 0.74 -1.33%
CAV 0.74 -1.33%
More..

Pacific Edge Ltd (NZE: PEB)

PEB Technical Analysis 3
As on 19th Jan 2017 PEB Share Price closed @ 0.55 and we RECOMMEND Buy for LONG-TERM with Stoploss of 0.55 & Buy for SHORT-TERM with Stoploss of 0.54 we also expect STOCK to react on Following IMPORTANT LEVELS.
PEB Target for January
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
PEB Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Medical Laboratories & Research
Offical website http://www.pacificedge.co.nz
PEB Address
PEB
87 Saint David Street
PO Box 56
Dunedin, 9016
New Zealand
Phone: 64 3 479 5800
Fax: 64 3 479 5801
PEB Latest News
Investor Scope: Taking a Closer Look at Shares of Pacific Edge Limited (NZSE:PEB)   Marion Business Daily   - 18th Jan 17
Pacific Edge announces commercial launch of Cxbladder Monitor in the U.S.   News-Medical.net   - 15th Dec 16
Pacific Edge Launches Cxbladder Monitor™ in the United States   PR Newswire (press release)   - 13th Dec 16
Pacific Edge introduces bladder cancer diagnostic test, Cxbladder Monitor in US   pharmabiz.com   - 13th Dec 16
Pacific Edge looks to steady growth   Otago Daily Times   - 25th Aug 16
Pacific Edge Unites with Partners to Launch Online Community for Bladder ...   PR Newswire (press release)   - 18th May 16
Pacific Edge Presents Positive Cxbladder Monitor™ Results   PR Newswire (press release)   - 17th May 16
Brokers downgrade Pacific Edge views   Otago Daily Times   - 08th Nov 15
Research Shows Pacific Edge's Cxbladder Detect Outperforms Other Non-Invasive ...   PR Newswire (press release)   - 26th May 15
Pacific Edge's Cxbladder Triage™ Accurately Stratifies Patients with Bladder ...   PR Newswire (press release)   - 19th May 15
Interactive Technical Analysis Chart Pacific Edge Ltd ( PEB NZE NewZealand )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Pacific Edge Ltd
PEB Business Profile
Pacific Edge Limited, a biomedical company, engages in the discovery, development, and commercialization of diagnostic and prognostic tools for the early detection and management of cancer. It offers Cxbladder, a non-invasive urine based test for the detection of bladder cancer; and Cxcolorectal, a prognostic gene signature for patients diagnosed with stage II or stage III colorectal cancer. The company’s products in development and clinical trial stage include gastric cancer diagnosis and prognosis, gastric cancer triage, and melanoma diagnosis and prognosis. It also manages and operates laboratories for the detection of bladder cancer. The company was formerly known as Pacific Edge Biotechnology Limited and changed its name to Pacific Edge Limited in April 2010. Pacific Edge Limited was founded in 2001 and is based in Dunedin, New Zealand.